Guerbet Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
David Hale
Chief executive officer
€1.5m
Total compensation
| CEO salary percentage | 31.7% |
| CEO tenure | 4.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 6.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €1m | €470k | €24m |
| Sep 30 2023 | n/a | n/a | -€9m |
| Jun 30 2023 | n/a | n/a | -€42m |
| Mar 31 2023 | n/a | n/a | -€42m |
| Dec 31 2022 | €1m | €470k | -€41m |
| Sep 30 2022 | n/a | n/a | -€14m |
| Jun 30 2022 | n/a | n/a | €13m |
| Mar 31 2022 | n/a | n/a | €23m |
| Dec 31 2021 | €2m | €470k | €33m |
| Sep 30 2021 | n/a | n/a | €33m |
| Jun 30 2021 | n/a | n/a | €33m |
| Mar 31 2021 | n/a | n/a | €26m |
| Dec 31 2020 | €933k | €470k | €18m |
Compensation vs Market: David's total compensation ($USD1.59M) is above average for companies of similar size in the German market ($USD1.02M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Hale (55 yo)
4.3yrs
Tenure
€1,481,777
Compensation
Mr. David Hale served as Independent Director of Orpea SA since July 28, 2022 until January 2024. He has been Chief Executive Officer of Guerbet SA since January 1, 2020 and serves as its MD & GM. Mr. Hale...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & GM | 4.3yrs | €1.48m | no data | |
| CFO and Senior VP of Business Development & Licensing | 5yrs | no data | no data | |
| Senior VP of Technical Operations & Interim Chief Pharmacist | 3.2yrs | no data | no data | |
| Director of Legal Affairs | 8.3yrs | no data | no data | |
| Senior Vice President of Public Affairs & Corporate Communications | no data | no data | no data | |
| Senior Vice President of Human Resources | no data | no data | no data | |
| Senior Vice President of Interventional Imaging | 3.3yrs | no data | no data | |
| Senior VP of R&D | 6.6yrs | no data | no data | |
| Senior Vice President of Diagnostic Imaging | 4.3yrs | no data | no data | |
| Senior Vice President of Commercial Operations - Asia-Pacific | 4.3yrs | no data | no data | |
| Senior Vice President of Commercial Operations - Americas & EMEA | 4.3yrs | no data | no data | |
| Chief Pharmacist | 4.3yrs | €11.50k | no data |
4.3yrs
Average Tenure
55yo
Average Age
Experienced Management: 4G8's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 6.9yrs | €44.40k | no data | |
| Honorary Chairman | no data | €18.96k | 55.13% € 259.3m | |
| Non-Independent Director | 10.9yrs | €27.60k | no data | |
| Non-Independent Director | 9.9yrs | €27.60k | no data | |
| Independent Chair of the Board | 9.9yrs | €109.68k | no data | |
| Non-Independent Director | 8.9yrs | €27.60k | no data | |
| Non-Independent Director | 7.9yrs | €32.40k | no data | |
| Non-Independent Director | 6.9yrs | €30.00k | no data | |
| Employee Director | 3.5yrs | no data | no data | |
| Employee Director | 3.1yrs | no data | no data | |
| Non-Independent Director | 2.9yrs | €21.20k | no data | |
| Non-Independent Director | 1.9yrs | €16.40k | no data |
6.9yrs
Average Tenure
53yo
Average Age
Experienced Board: 4G8's board of directors are considered experienced (6.9 years average tenure).